• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Vanguard Scientific Announces Partnership with Rymedi

Share:

December 16, 2019

Vanguard Scientific Systems, Inc., a premier provider of equipment, systems and performance solutions servicing the botanical extraction industry, has announced a strategic partnership and exclusive industry licensing partnership with Rymedi, a global leader in block-chain enabled compliance, traceability and regulatory adherence technologies. Utilizing Rymedi’s expertise in global pharmaceutical regulatory compliance, the Company will be able to enhance their offerings to enable clients the capability to meet the domestic and international regulatory requirements of the cannabinoid industry.

The partnership will offer leading-edge expertise and solution-based services which include, GS1 global labeling standardization, international as well as domestic export readiness and product conformity, Quality Management System development as well as on demand document control and validation for clients looking to provide high-quality products of CGP and pharma-grade standards.

“As the Cannabinoid market continues to expand and regulations are being defined by state, country and region, understanding and navigating the evolving landscape of compliance can make the difference between generating revenue and producing a product which cannot be sold,” said CEO of Vanguard Scientific, Matthew Anderson. “For companies, especially ones navigating the U.S. hemp industry, having a team of quality experts and a technological solution providing an additional layer of compliance support will be the key to long-term consumer and patient success.”

“With our experience in highly regulated markets and Vanguard’s advanced processing systems, we’re perfectly positioned to deliver immutable compliance which is required to deliver trusted, high quality products – especially in geographies and industries where fraud and compliance concerns remain high,” said CEO of Rymedi, David Stefanich.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The entire suite of Vanguard Quality Products and Solutions are now available to clients globally. By engaging with a Vanguard integration specialist, clients are able to receive an initial gap analysis and review of current operations in order to assure that their goals and desired product targets are being appropriately planned for, and the quality systems required are developed and implemented to meet the market.

Source: Prnews Wire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Artificial Intelligence – Leading The Silent Revolution in HealthCareArtificial Intelligence – Leading The Silent Revolution in HealthCare
  • FDA Greenlights Medtronic’s AI Tool That Finds Polyps During ColonoscopiesFDA Greenlights Medtronic’s AI Tool That Finds Polyps During Colonoscopies
  • Integer Holdings Corporation Announces Preliminary Unaudited Sales Results and Acquisition of Pulse TechnologiesInteger Holdings Corporation Announces Preliminary Unaudited Sales Results and Acquisition of Pulse Technologies
  • Imprivata Launches First-to-Market Mobile Facial Recognition SolutionImprivata Launches First-to-Market Mobile Facial Recognition Solution
  • Elevating the Hospital Room Waiting Experience: 6 Factors to ConsiderElevating the Hospital Room Waiting Experience: 6 Factors to Consider
  • Nectar Lifesciences Shares Surge on Buyback NewsNectar Lifesciences Shares Surge on Buyback News
  • GE Healthcare leverages AI and Data Integration for Patient CareGE Healthcare leverages AI and Data Integration for Patient Care
  • FDA sought new PreCert participants, cleared new digital health products and more during Q2 2019FDA sought new PreCert participants, cleared new digital health products and more during Q2 2019

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications